TIDMCRW

RNS Number : 1097G

Craneware plc

25 March 2022

Craneware plc

("Craneware" or the "Company" or the "Group")

Dividend Currency Election

25 March 2022 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, today gives further information regarding its interim dividend announced on 14 March 2022.

For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.32.

For further information, please contact:

 
 
 Craneware plc                                                 +44 (0)131 550 3100 
 Keith Neilson, CEO 
 Craig Preston, CFO 
 
 
 Alma (Financial PR)                                           +44 (0)20 3405 0205 
 Caroline Forde, Hilary Buchanan, Joe Pederzolli               craneware@almapr.co.uk 
 
 
 Peel Hunt (NOMAD and Joint Broker)                            +44 (0)20 7418 8900 
 Dan Webster, Andrew Clark 
 
 
 Investec Bank PLC (Joint Broker)                              +44 (0)20 7597 5970 
 Patrick Robb, Henry Reast, Sebastian Lawrence 
 
 Berenberg (Joint Broker )                                     +44 (0)20 3207 7800 
 Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff

About Craneware

We at the Craneware Group of companies, including our latest additions Sentry Data Systems and Agilum Healthcare Intelligence, passionately believe we can impact healthcare profoundly by delivering the insights healthcare organizations need to also transform the business of healthcare. Our shared vision is to be the operational and financial partner for U.S. healthcare providers.

Our combined suite of applications and industry-leading team of experts help our customers contextualize operational, financial, and clinical data, providing insights that clearly demonstrate what great looks like. These value cycle insights deliver revenue integrity and 340B compliance, as well as margin and operational intelligence - something no other single partner can provide.

Together, approximately 40% of registered U.S. hospitals are now our customers, including more than 2,000 U.S hospitals and health systems and almost 10,000 clinics and affiliated retail pharmacies. Our customers are operating with a financial impact of nearly half a trillion dollars. We have data sets from customers covering more than 150 million unique patients encounters.

Learn more at www.craneware.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DIVEALDSAFLAEFA

(END) Dow Jones Newswires

March 25, 2022 10:16 ET (14:16 GMT)

Craneware (LSE:CRW)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Craneware Charts.
Craneware (LSE:CRW)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Craneware Charts.